» Articles » PMID: 32488123

ROS-Mediated Apoptotic Cell Death of Human Colon Cancer LoVo Cells by Milk δ-Valerobetaine

Overview
Journal Sci Rep
Specialty Science
Date 2020 Jun 4
PMID 32488123
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

δ-Valerobetaine (δVB) is a constitutive milk metabolite with antioxidant and anti-inflammatory activities. Here, we tested the antineoplastic properties of milk δVB on human colorectal cancer cells. CCD 841 CoN (non-tumorigenic), HT-29 (p53 mutant adenocarcinoma) and LoVo (APC/RAS mutant adenocarcinoma) cells were exposed to 3 kDa milk extract, δVB (2 mM) or milk+δVB up to 72 h. Results showed a time- and dose-dependent capability of δVB to inhibit cancer cell viability, with higher potency in LoVo cells. Treatment with milk+δVB arrested cell cycle in G2/M and SubG1 phases by upregulating p21, cyclin A, cyclin B1 and p53 protein expressions. Noteworthy, δVB also increased necrosis (P < 0.01) and when used in combination with milk it improved its activity on live cell reduction (P < 0.05) and necrosis (P < 0.05). δVB-enriched milk activated caspase 3, caspase 9, Bax/Bcl-2 apoptotic pathway and reactive oxygen species (ROS) production, whereas no effects on ROS generation were observed in CCD 841 CoN cells. The altered redox homeostasis induced by milk+δVB was accompanied by upregulation of sirtuin 6 (SIRT6). SIRT6 silencing by small interfering RNA blocked autophagy and apoptosis activated by milk+δVB, unveiling the role of this sirtuin in the ROS-mediated apoptotic LoVo cell death.

Citing Articles

SGLT2 inhibitor promotes mitochondrial dysfunction and ER-phagy in colorectal cancer cells.

Anastasio C, Donisi I, Del Vecchio V, Colloca A, Mele L, Sardu C Cell Mol Biol Lett. 2024; 29(1):80.

PMID: 38811901 PMC: 11134909. DOI: 10.1186/s11658-024-00599-1.


Metabolic Alteration Bridging the Prediabetic State and Colorectal Cancer.

Colloca A, Donisi I, Anastasio C, Balestrieri M, DOnofrio N Cells. 2024; 13(8.

PMID: 38667278 PMC: 11049175. DOI: 10.3390/cells13080663.


Dietary Epigenetic Modulators: Unravelling the Still-Controversial Benefits of miRNAs in Nutrition and Disease.

Martino E, DOnofrio N, Balestrieri A, Colloca A, Anastasio C, Sardu C Nutrients. 2024; 16(1).

PMID: 38201989 PMC: 10780859. DOI: 10.3390/nu16010160.


Hibiscus Anthocyanins Extracts Induce Apoptosis by Activating AMP-Activated Protein Kinase in Human Colorectal Cancer Cells.

Tsai M, Chen C, Tseng T, Chang Y, Lin Y, Tsai I Nutrients. 2023; 15(18).

PMID: 37764756 PMC: 10535221. DOI: 10.3390/nu15183972.


Chemopreventive effect of a milk whey by-product derived from Buffalo (Bubalus bubalis) in protecting from colorectal carcinogenesis.

Cacciola N, Venneri T, Salzano A, DOnofrio N, Martano M, Saggese A Cell Commun Signal. 2023; 21(1):245.

PMID: 37730576 PMC: 10510155. DOI: 10.1186/s12964-023-01271-5.


References
1.
Vieira A, Abar L, Chan D, Vingeliene S, Polemiti E, Stevens C . Foods and beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR Continuous Update Project. Ann Oncol. 2017; 28(8):1788-1802. DOI: 10.1093/annonc/mdx171. View

2.
Gao T, Li M, Mu G, Hou T, Zhu W, Yang Y . PKCζ Phosphorylates SIRT6 to Mediate Fatty Acid β-Oxidation in Colon Cancer Cells. Neoplasia. 2018; 21(1):61-73. PMC: 6277223. DOI: 10.1016/j.neo.2018.11.008. View

3.
Van Meter M, Gorbunova V, Seluanov A . SIRT6: a promising target for cancer prevention and therapy. Adv Exp Med Biol. 2014; 818:181-96. DOI: 10.1007/978-1-4471-6458-6_9. View

4.
Khan I, Nadeem M, Imran M, Ullah R, Ajmal M, Jaspal M . Antioxidant properties of Milk and dairy products: a comprehensive review of the current knowledge. Lipids Health Dis. 2019; 18(1):41. PMC: 6362592. DOI: 10.1186/s12944-019-0969-8. View

5.
Liu W, Wu M, Du H, Shi X, Zhang T, Li J . SIRT6 inhibits colorectal cancer stem cell proliferation by targeting CDC25A. Oncol Lett. 2018; 15(4):5368-5374. PMC: 5840749. DOI: 10.3892/ol.2018.7989. View